BackRAPT Therapeutics Overview

RAPT Therapeutics Selling, General & Admin

Selling, General & Admin expenses for RAPT.

Quarterly SG&A Expenses

$7.34M
↑ 13.79% YoY

As of Sep 30, 2025

Annual SG&A Expenses (TTM)

$29.56M
↑ 12.04% YoY

Trailing 12 months ending Sep 30, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin